PopperO.W.Psychopharmacologic treatment of anxiety disorders in adolescents and children.J Clin Psychiatry1993; 54(Suppl 5): 52–63.
2.
CohnJ.B., WilcoxC.S.Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study.J Clin Psychiatry1986; 47: 409–412.
3.
BalsterR.L.Abuse potential of buspirone and related drugs.J Clin Psychopharmacol1990; 10(Suppl 3): 31S–37S.
4.
KutcherS.P., ReiterS., GardnerD.M.The pharmacotherapy of anxiety disorders in children and adolescents. In: ShafferD., ed. Pediatric psychopharmacology. Psychiatric Clinic of North America.Philadelphia: WB Saunders Co.,1990; 15: 41–67.
5.
KranzlerH.R.Use of buspirone in an adolescent with overanxious disorder.J Am Acad Child Adolesc Psychiatry1988; 6: 789–790.
6.
AlessiN., BosT.Buspirone augmentation of fluoxetine in a depressed child with obsessive-compulsive disorder.Am J Psychiatry1991; 148: 1605–1606.
7.
Diagnostic and statistical manual of mental disorders, third edition, revised. Washington DC: American Psychiatric Press, Inc.,1987.